Ironically I have spent most of my working life in the "big instos".
The cost to them is negligible because they sub let the underwriting.
The underwriting insto gets a fee from SLR and derisks this by giving other instos sub underwriten allocations. Yes this was fully underwritten by RBS - pointlessly it seems given the raise price to current.
The reason its cheaper than a rights issue is because instos do not require expensive PDS's; plain and simple.
My gripe is simple - the rush for money is not (from what I can see) needed yesterday.
With no need to rush the balance sheet fix, there is no need to save a few 100,000 in corporate (tax deductible) costs to simply throw instos freebies.
This is not an equitable position for a company not in stress. This is the kind of thing Lynas does.
- Forums
- ASX - By Stock
- SLR
- 85c - what a shame!
85c - what a shame!, page-54
Featured News
Add SLR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online